Skip to main content

Table 3 Adequacy of glycaemic management in diabetic patients on follow-up at JUSH, November 2009

From: Assessment of quality of care given to diabetic patients at Jimma University Specialized Hospital diabetes follow-up clinic, Jimma, Ethiopia

  FBS  
Treatment categories Average FBS, mg/dl ≤ 130 mg/dl > 130 mg/dl P-value
   N % N %  
Pharmacotherapeutic options       
   Insulin alone 170.8 37 23.6 120 76.4  
   Insulin and OGLA 190.3 3 23.1 10 76.9 0.0006
   One OGLA 152.7 28 41.8 39 58.2  
   Both OGLA 188.7 15 22.4 59 77.6  
Doses of drugs       
   Insulin       
   < 1IU/Kg/d 167.7 36 25.5 105 74.5 0.175
    1IU/kg/d 194.5 4 13.8 25 86.2  
Glibenclamide (G)       
   < 20 mg/d 149.4 30 50.0 30 50.0 0.0001
    20 mg/d 190.0 11 15.1 62 84.9  
Metformin(M)       
   < 1000 mg/d 163.1 15 38.5 24 61.5 0.001
    1000 mg/d 204.3 5 8.9 52 91.1  
Glibenclamide + metformin       
   G < 20 mg/d or M < 1000 mg/d 168.1 12 36.4 21 63.6 0.005
   G 20 mg/d & M 1000 mg/d 203.3 4 9.5 38 90.5  
Modification of glycaemic treatment during the last 3 visits      
   Yes 16* 19.0 70 30.7  
   No 68 81.0 158 69.3  
  1. * In 13 of these patients treatment modification was for low FBS or symptoms of hypoglycemia.